Novo Nordisk to begin 2024 share buybacks By Reuters

© Reuters. FILE PHOTO: A general view of the Novo Nordisk headquarters building in Bagsvaerd, Denmark, Wednesday January 31, 2024. Ritzau Scanpix/Mads Claus Rasmussen via REUTERS /File Photo

OSLO (Reuters) – Novo Nordisk (NYSE:) will on Tuesday begin the execution of its planned share buyback programme for 2024, the Danish maker of obesity drug Wegovy and diabetes treatment Ozempic said in a statement.

Novo on Jan. 31 said it planned to carry out a share repurchase plan of up to 20 billion Danish crowns ($2.88 billion) to reduce the company’s share capital and to meet obligations arising from share-based incentive programmes.

The company completed its previous 12-month share repurchase programme on Jan. 30.

($1 = 6.9337 Danish crowns)

Source link

Leave a Comment